US FDA expands approval for J&J's drug for rare blood disorder
US FDA expands approval for J&J's drug for rare blood disorder Aug 24 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's JNJ.N drug to treat a rare blood disorder, the company said on Monday.
(Reporting by Kunal Das and Padmanabhan Ananthan in Bengaluru; Editing by Vijay Kishore)
Recent news on Johnson & Johnson
See all newsEli Lilly hits record high as healthcare stocks rally
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Brief: Johnson & Johnson Announces New Data For Tremfya
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin